AI drug discovery company

Cradle

Data as of Oct 17, 2026.

Company facts

Founded

2021

ReportedSource for founded (opens in new tab)
Headquarters

Netherlands (Amsterdam) and Switzerland (Zurich)

ConfirmedSource for headquarters (opens in new tab)
Total funding

over $100M

ConfirmedSource for total funding (opens in new tab)

Latest funding round

Round: Series B
Date: Nov 26, 2024
Amount: $73M
Lead investor: IVP

ConfirmedSource for the latest round (opens in new tab)

Drug discovery partners

2 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

Lundbeck Pharma

Antibody programs, Jun 3, 2026

Terms not disclosed

ConfirmedSource for Lundbeck (opens in new tab)
Bayer Pharma

Antibody optimization collaboration, Jan 16, 2026

Terms not disclosed

ConfirmedSource for Bayer (opens in new tab)

Recent news

Jun 3, 2026

Lundbeck partnership on two CNS antibody programs

ConfirmedSource (opens in new tab)
Mar 9, 2026

Introduces CRADLE-1, a machine learning framework for protein lead optimization

ConfirmedSource (opens in new tab)
Jan 16, 2026

Strategic collaboration with Bayer on generative AI antibody optimization

ConfirmedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.